Mackenzie Financial Corp Dexcom Inc Transaction History

Mackenzie Financial Corp

$66.8 Billion
Q3 2024

A detailed history of Mackenzie Financial Corp transactions in Dexcom Inc stock. As of the latest transaction made, Mackenzie Financial Corp holds 1,295,371 shares of DXCM stock, worth $98.8 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares

1,295,371

Previous 821,192 57.74%

Holding current value

$98.8 Million

Previous $93.1 Million 6.76%

% of portfolio

0.13%

Previous 0.15%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$64.0 - $116.06 $30.3 Million - $55 Million	474,179 Added 57.74%	1,295,371 $86.8 Million
Q2 2024 Aug 14, 2024	BUY	$110.31 - $140.45 $8.22 Million - $10.5 Million	74,473 Added 9.97%	821,192 $93.1 Million
Q1 2024 May 10, 2024	SELL	$114.22 - $140.1 $335,007 - $410,913	-2,933 Reduced 0.39%	746,719 $104 Million
Q4 2023 Jan 30, 2024	BUY	$75.49 - $124.16 $7.23 Million - $11.9 Million	95,829 Added 14.66%	749,652 $93 Million
Q3 2023 Oct 25, 2023	BUY	$86.06 - $137.93 $13.2 Million - $21.2 Million	153,556 Added 30.69%	653,823 $61 Million
Q2 2023 Aug 03, 2023	SELL	$112.47 - $130.98 $3.5 Million - $4.07 Million	-31,106 Reduced 5.85%	500,267 $64.3 Million
Q1 2023 Apr 24, 2023	SELL	$104.0 - $122.92 $2.39 Million - $2.83 Million	-23,009 Reduced 4.15%	531,373 $61.7 Million
Q4 2022 Feb 14, 2023	BUY	$84.98 - $122.67 $3.07 Million - $4.43 Million	36,108 Added 6.97%	554,382 $62.8 Million
Q3 2022 Oct 07, 2022	BUY	$76.35 - $94.18 $6.16 Million - $7.6 Million	80,678 Added 18.44%	518,274 $41.7 Million
Q2 2022 Aug 10, 2022	BUY	$67.99 - $132.89 $27.7 Million - $54.2 Million	408,080 Added 1382.57%	437,596 $32.6 Million
Q1 2022 May 13, 2022	BUY	$94.08 - $130.2 $579,532 - $802,031	6,160 Added 26.37%	29,516 $15.1 Million
Q4 2021 Feb 14, 2022	BUY	$129.87 - $162.82 $482,856 - $605,364	3,718 Added 18.93%	23,356 $12.5 Million
Q3 2021 Nov 08, 2021	BUY	$106.71 - $143.18 $90,169 - $120,987	845 Added 4.5%	19,638 $10.7 Million
Q2 2021 Aug 11, 2021	BUY	$80.99 - $107.93 $71,028 - $94,654	877 Added 4.9%	18,793 $8.03 Million
Q1 2021 May 14, 2021	BUY	$84.79 - $104.74 $129,728 - $160,252	1,530 Added 9.34%	17,916 $6.44 Million
Q4 2020 Feb 10, 2021	BUY	$78.0 - $104.5 $126,126 - $168,976	1,617 Added 10.95%	16,386 $6.06 Million
Q3 2020 Nov 13, 2020	SELL	$95.51 - $112.95 $253,388 - $299,656	-2,653 Reduced 15.23%	14,769 $6.09 Million
Q2 2020 Aug 13, 2020	SELL	$62.68 - $105.34 $54,218 - $91,119	-865 Reduced 4.73%	17,422 $1.77 Million
Q1 2020 May 14, 2020	SELL	$47.79 - $75.63 $25 Million - $39.6 Million	-524,153 Reduced 96.63%	18,287 $1.23 Million
Q4 2019 Feb 13, 2020	SELL	$36.62 - $57.29 $9.3 Million - $14.5 Million	-253,902 Reduced 31.88%	542,440 $119 Million
Q3 2019 Nov 14, 2019	SELL	$35.53 - $43.8 $1.41 Million - $1.74 Million	-39,634 Reduced 4.74%	796,342 $119 Million
Q2 2019 Aug 14, 2019	SELL	$27.84 - $38.92 $6.82 Million - $9.53 Million	-244,910 Reduced 22.66%	835,976 $125 Million
Q1 2019 May 15, 2019	BUY	$28.07 - $38.18 $8.78 Million - $11.9 Million	312,915 Added 40.75%	1,080,886 $129 Million
Q4 2018 Feb 06, 2019	BUY	$26.99 - $37.37 $2.49 Million - $3.45 Million	92,289 Added 13.66%	767,971 $92 Million
Q3 2018 Nov 15, 2018	SELL	$23.35 - $36.72 $7.95 Million - $12.5 Million	-340,618 Reduced 33.52%	675,682 $96.7 Million
Q2 2018 Aug 13, 2018	SELL	$17.54 - $25.22 $7.23 Million - $10.4 Million	-412,090 Reduced 28.85%	1,016,300 $96.5 Million
Q1 2018 May 14, 2018	BUY	$13.06 - $18.54 $741,742 - $1.05 Million	56,795 Added 4.14%	1,428,390 $106 Million
Q4 2017 Feb 13, 2018	BUY	$11.12 - $15.38 $976,869 - $1.35 Million	87,848 Added 6.84%	1,371,595 $78.7 Million
Q3 2017 Nov 13, 2017	BUY	$11.36 - $18.98 $1.79 Million - $3 Million	157,962 Added 14.03%	1,283,747 $62.8 Million
Q2 2017 Aug 14, 2017	BUY	N/A	1,125,785	1,125,785 $82.4 Million

Others Institutions Holding DXCM

# of Institutions

1,013

Shares Held

351M

Call Options Held

5.51M

Put Options Held

5.6M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $29.5B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mackenzie Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Mackenzie Financial Corp with notifications on news.

Account

Mackenzie Financial Corp Dexcom Inc Transaction History